Related Experiment Video
Updated: Jun 1, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling
Frank Echtermeyer1, Thomas Harendza, Svenja Hubrich
1Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Carl-Neuberg Str. 1, 30625 Hannover, Germany.
Aims:
Myocardial infarction (MI) results in acute impairment of left ventricular (LV) function through the initial development of cardiomyocyte death and subsequent progression of LV remodelling. The expression of syndecan-4 (Sdc4), a transmembrane proteoglycan, is up-regulated after MI, but its function in the heart remains unknown. Here, we characterize the effects of Sdc4 deficiency in murine myocardial ischaemia and permanent infarction.
Methods And Results:
Targeted deletion of Sdc4 (Sdc4(-/-)) leads to increased myocardial damage after ischaemic-reperfusion injury due to enhanced cardiomyocyte apoptosis associated with reduced activation of extracellular signal-regulated kinase in cardiomyocytes in vitro and in vivo. After ischaemic-reperfusion injury and permanent infarction, we observed an increase in cardiomyocyte area, nuclear translocation of nuclear factor of activated T cells (NFAT), and transcription of the NFAT target rcan1.4 in wild-type mice. NFAT pathway activation was enhanced in Sdc4(-/-) mice. In line with the in vivo data, NFAT activation and hypertrophy occurs in isolated cardiomyocytes with reduced Sdc4 expression during phenylephrine stimulation in vitro. Despite the initially increased myocardial damage, echocardiography revealed improved LV geometry and function in Sdc4(-/-) mice 7 days after MI.
Conclusion:
Interception of the Sdc4 pathway enhances infarct expansion and hypertrophic remodelling during early infarct healing in ischaemic-reperfusion injury and permanent infarction mouse models and exerts net beneficial effects on LV function.
Insights
Syndecan-4 (Sdc4) deficiency worsens early heart attack damage but improves left ventricular (LV) function and geometry later. Intercepting the Sdc4 pathway benefits LV function post-myocardial infarction.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Proteoglycan Research
Background:
- Myocardial infarction (MI) impairs left ventricular (LV) function via cardiomyocyte death and remodeling.
- Syndecan-4 (Sdc4) expression increases post-MI, but its cardiac role is unclear.
Purpose of the Study:
- To investigate the function of Sdc4 in the heart during myocardial ischemia and infarction.
- To characterize the effects of Sdc4 deficiency on cardiac response to injury.
Main Methods:
- Utilized Sdc4-deficient (Sdc4(-/-)) and wild-type mice subjected to myocardial ischemia-reperfusion and permanent infarction models.
- Assessed cardiomyocyte apoptosis, extracellular signal-regulated kinase (ERK) activation, and nuclear factor of activated T cells (NFAT) pathway activation.
- Evaluated LV geometry and function using echocardiography.
Main Results:
- Sdc4 deficiency exacerbated myocardial damage and cardiomyocyte apoptosis post-ischemia-reperfusion, linked to reduced ERK activation.
- NFAT pathway activation, cardiomyocyte hypertrophy, and rcan1.4 transcription increased in Sdc4(-/-) mice.
- Despite initial damage, Sdc4(-/-) mice showed improved LV geometry and function 7 days post-MI.
Conclusions:
- Sdc4 deficiency promotes infarct expansion and hypertrophic remodeling during early infarct healing.
- Targeting the Sdc4 pathway demonstrates net beneficial effects on LV function after myocardial infarction and ischemia-reperfusion injury.
Related Concept Videos
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Caspases
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Apoptosis
The JAK-STAT Signaling Pathway